老年慢性冠心病患者健康状况与临床结局:ISCHEMIA试验
本研究基于ISCHEMIA试验4617例慢性冠心病伴中重度缺血患者,评估年龄对侵入性与保守治疗在健康状况和临床结局方面的影响。结果显示,侵入性治疗改善心绞痛相关健康状况的幅度随年龄增长而减小,但心绞痛频率改善在各年龄组一致;侵入性治疗未改善任何年龄组的临床复合结局。
要点
- 侵入性治疗改善1年SAQ总分的幅度随年龄增长而减小。
- 心绞痛频率改善在各年龄组间无显著差异。
- 侵入性治疗未改善老年或年轻患者的临床复合结局。
核心结论
- 老年慢性冠心病伴中重度缺血患者接受侵入性治疗后心绞痛频率改善与年轻患者一致,但心绞痛相关健康状况改善较小。
- 侵入性治疗未改善老年或年轻患者的临床复合结局。
研究设计与样本
- ISCHEMIA试验的事后分析,纳入4617例慢性冠心病伴中重度缺血患者。
- 按年龄分组:<65岁2239例(48.5%),65-74岁1713例(37.1%),≥75岁665例(14.4%)。
- 采用7项西雅图心绞痛问卷(SAQ)评估1年心绞痛特异性健康状况。
- 采用Cox比例风险模型估计侵入性与保守治疗对不同年龄临床复合结局的治疗效应。
主要发现
- 基线SAQ汇总评分在<65岁参与者中较低。
- 完全校正后1年SAQ汇总评分差异(侵入性减保守性):55岁为4.90(95%CI 3.56-6.24),65岁为3.48(95%CI 2.40-4.57),75岁为2.13(95%CI 0.75-3.51),交互作用P=0.008。
- SAQ心绞痛频率改善对年龄的依赖较小,交互作用P=0.08。
- 侵入性与保守治疗对临床复合结局的影响无年龄差异,交互作用P=0.29。
临床怎么用
- 对老年慢性冠心病伴中重度缺血患者,侵入性治疗可改善心绞痛频率,但健康状况总体改善幅度小于年轻患者。
- 侵入性治疗未显示改善临床结局,决策时应结合患者年龄与症状负担个体化权衡。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Whether initial invasive management in older vs younger adults with chronic coronary disease and moderate or severe ischemia improves health status or clinical outcomes is unknown. OBJECTIVES: The goal of this study was to examine the impact of age on health status and clinical outcomes with invasive vs conservative management in the ISCHEMIA (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches) trial. METHODS: One-year angina-specific health status was assessed with the 7-item Seattle Angina Questionnaire (SAQ) (score range 0-100; higher scores indicate better health status). Cox proportional hazards models estimated the treatment effect of invasive vs conservative management as a function of age on the composite clinical outcome of cardiovascular death, myocardial infarction, or hospitalization for resuscitated cardiac arrest, unstable angina, or heart failure. RESULTS: Among 4,617 participants, 2,239 (48.5%) were aged <65 years, 1,713 (37.1%) were aged 65 to 74 years, and 665 (14.4%) were aged ≥75 years. Baseline SAQ summary scores were lower in participants aged <65 years. Fully adjusted differences in 1-year SAQ summary scores (invasive minus conservative) were 4.90 (95% CI: 3.56-6.24) at age 55 years, 3.48 (95% CI: 2.40-4.57) at age 65 years, and 2.13 (95% CI: 0.75-3.51) at age 75 years (Pinteraction = 0.008). Improvement in SAQ Angina Frequency was less dependent on age (Pinteraction = 0.08). There were no age differences between invasive vs conservative management on the composite clinical outcome (Pinteraction = 0.29). CONCLUSIONS: Older patients with chronic coronary disease and moderate or severe ischemia had consistent improvement in angina frequency but less improvement in angina-related health status with invasive management compared with younger patients. Invasive management was not associated with improved clinical outcomes in older or younger patients. (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches [ISCHEMIA]; NCT01471522).
引用
- Nguyen DD, Spertus JA, Alexander KP, et al. Health Status and Clinical Outcomes in Older Adults With Chronic Coronary Disease: The ISCHEMIA Trial. J Am Coll Cardiol. 2023. PMID: 37100486. doi:10.1016/j.jacc.2023.02.048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。